CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...

Researchers uncover how the SiPRR37 gene regulates the flowering process of millet crops across regional climates, paving way ...

The US government has provided almost $24 million in funding to Locus Biosciences to support ... that has been modified using CRISPR/Cas3 gene-editing to improve its ability to target the E ...

Together, these findings establish CREATE as a programmable, RNA-based gene delivery technology with broad therapeutic potential. CREATE is a genome editing system that combines CRISPR/Cas9 with ...

In theory, CRISPR gene editing could be used to make any modification to ... Several companies are also stepping away from the cas9 protein to develop their CRISPR-based therapies. Locus Biosciences ...